• Via Ritzau pressemeddelelser
  • Via Ritzau selskabsmeddelelser
  • Globenewswire
  • Business Wire
  • ACCESSWIRE
RealMæglerne

Boligsalget faldt 20 % i juli27.7.2021 13:36:00 CEST | RealMæglerne

RealMæglernes BoligBarometer / juli (baseret på mere end 100 butikkers landsdækkende salgstal og boligstatistikker fra Boligsiden.dk) viser, at det er blevet hverdag på boligmarkedet igen. Festen er forbi, og nu er det ferietid: – I takt med, at køberinteressen er svagt aftagende, betyder det også, at priserne fremover vil bevæge sig imod en normalisering med bedre balance mellem købere og sælgere, hvor vi vil se en årlig gennemsnitlig prisudvikling på 4 %, fortæller Preben Merrild Angelo, adm. direktør hos RealMæglerne.
Grünenthal Group

Grünenthal’s Glucocorticoid Receptor Modulator enters clinical development27.7.2021 10:59:55 CEST | Grünenthal Group

Aachen, Germany, 27 July 2021 –Grünenthal announced today that the first volunteers have been enrolled in a Phase I trial of its Glucocorticoid Receptor Modulator (GRM). The oral investigational medicine aims to provide a therapy option with broad anti-inflammatory efficacy and a more favourable benefit-risk profile compared to current glucocorticoid-based therapies like prednisolone. The Phase I trial includes 80 healthy volunteers and is designed as a head to head comparison between the GRM and prednisolone, the most frequently used glucocorticoid.[1] Observing several biomarkers, the trial will assess the influence of the investigational medicine on bone metabolism and glucose levels. Reduced bone formation leading to osteoporosis as well as increased blood glucose levels leading to an increased risk of diabetes are among the most common side-effects of glucocorticoids, which are a strong limitation for their long-term use at highly effective doses.[2],[3],[4] The results of the stu
msg life ag

msg life and IBM strengthen insurance digitization by leveraging leading End-To-End platform capabilities for the life insurance & pensions industry outside the German-speaking countries27.7.2021 10:12:46 CEST | msg life ag

Leinfelden-Echterdingen/Ehningen, 27 July 2021 – msg life and IBM Germany are collaborating on the implementation of the msg.Insurance Suite Life, combined with IBM Global Business Services’ core competencies of consulting, implementation and migration. The joint value proposition by IBM and msg life supports insurance companies in the end-to-end digitisation of their life and pension business and can thus strengthen their competitiveness significantly. Leading insurance companies across Europe are already benefiting from the joint solution proposed by msg life and IBM. The msg.Insurance Suite Life is an innovative digital software platform that tracks the entire value chain of life insurance companies and pension providers. At the heart of the platform is the leading European policy administration solution msg.Life Factory. It offers insurers the concentrated know-how of more than 40 years’ experience in the industry, the security of msg life’s unique track record, combined with innov
Dancann Pharma

DanCann Pharma forhøjer aktiekapitalen markant med fokus på større produktionskapacitet og eksport til det tyske marked27.7.2021 10:12:38 CEST | Dancann Pharma

På en ekstraordinær generalforsamling den 23. juli 2021 fik bestyrelsen for DanCann Pharma A/S bemyndigelse til at udstede i alt 1.702.339 nye aktier i selskabet til kurs DKK 3,745, hvilket svarer til lukkekursen d. 22. juli før den ekstraordinære generalforsamling fandt sted. Kapitalforhøjelsen tilfører selskabet ca. DKK 6,375 mio., som skal bruges på at øge produktionskapaciteten med henblik eksport til det tyske marked.
DEAS

DEAS Group strengthens its international perspective with appointment of Rikke Lykke as new Group CEO27.7.2021 07:41:03 CEST | DEAS

DEAS Group, consisting of DEAS A/S and DEAS Asset Management A/S, has over the last years transformed from a Danish property management company to a Nordic full-service partner to property investors. A significant step on this journey was made earlier this year with the acquisition of Aberdeen Standard Investments’ direct Nordic real estate activities – and DEAS Group aims to continue this strategic expansion. To this end, DEAS Group’s Board of Directors is pleased to announce the appointment of Rikke Lykke as new Group CEO. Rikke Lykke will assist and accelerate the strategic development of the Group at an international level. She will join on 1 August 2021. “Rikke Lykke brings an international profile that will strengthen our senior leadership capabilities with a strong track record and expertise within professional management and investment in real estate and has excellent knowledge of Nordic and international property markets. On behalf of the Board of Directors, I welcome Rikke to
DEAS

DEAS styrker sit internationale perspektiv. Rikke Lykke tiltræder som ny Group CEO for DEAS Gruppen27.7.2021 07:39:56 CEST | DEAS

DEAS Gruppen, der består af DEAS A/S og DEAS Asset Management A/S, har de senere år gennemgået en transformation fra at være et dansk ejendomsforvaltningsselskab til at være en nordisk full-service samarbejdspartner overfor ejendomsinvestorer. Et betydningsfuldt skridt på denne rejse blev taget tidligere på året med opkøbet af Aberdeen Standard Investments nordiske aktiviteter inden for fast ejendom – og DEAS Gruppen ønsker at fortsætte denne strategiske udvikling. DEAS Gruppens bestyrelse er glade for at kunne meddele ansættelsen af Rikke Lykke som ny CEO for DEAS Gruppen. Rikke Lykke skal bistå og accelerere den strategiske udvikling af koncernen på internationalt plan. Rikke Lykke tiltræder 1. august 2021. "Rikke Lykke bibringer en international profil, som vil styrke vores øverste ledelse med internationale kompetencer og en stærk track record og ekspertise inden for management af og investering i fast ejendom, og hun besidder en stor viden om det nordiske og internationale ejendom
  • 1
  • 2
  • 3
  • 4
  • 5
  • Sidste
  • >>